Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
2.310
-0.060 (-2.53%)
At close: Apr 28, 2026, 4:00 PM EDT
2.310
0.00 (0.00%)
After-hours: Apr 28, 2026, 7:35 PM EDT
Lipocine Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 1.98 | 11.2 | -2.85 | 0.5 | 16.14 | |
| Revenue Growth (YoY) | -82.35% | - | - | -96.90% | - | |
| Gross Profit | 1.98 | 11.2 | -2.85 | 0.5 | 16.14 | |
| Selling, General & Admin | 3.76 | 5 | 4.9 | 4.06 | 5.33 | |
| Research & Development | 8.58 | 7.35 | 10.18 | 8.56 | 7.67 | |
| Operating Expenses | 12.35 | 12.35 | 15.08 | 12.62 | 13 | |
| Operating Income | -10.37 | -1.16 | -17.93 | -12.12 | 3.15 | |
| Interest Expense | - | - | - | -0.03 | -0.2 | |
| Interest & Investment Income | 0.74 | 1.15 | 1.37 | 0.57 | 0.07 | |
| Other Non Operating Income (Expenses) | - | 0.02 | 0.21 | 0.57 | 0.36 | |
| EBT Excluding Unusual Items | -9.63 | 0.01 | -16.35 | -11.01 | 3.37 | |
| Legal Settlements | - | - | - | 0.25 | -4 | |
| Pretax Income | -9.63 | 0.01 | -16.35 | -10.76 | -0.63 | |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | |
| Net Income | -9.63 | 0.01 | -16.35 | -10.76 | -0.63 | |
| Preferred Dividends & Other Adjustments | - | - | 0 | - | - | |
| Net Income to Common | -9.63 | 0.01 | -16.35 | -10.76 | -0.63 | |
| Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | |
| Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | |
| Shares Change (YoY) | 0.48% | 2.90% | 0.26% | 1.98% | 57.35% | |
| EPS (Basic) | -1.77 | 0.00 | -3.10 | -2.06 | -0.12 | |
| EPS (Diluted) | -1.77 | -0.00 | -3.14 | -2.15 | -0.19 | |
| Free Cash Flow | -9.76 | -1.31 | -11.88 | -12.1 | -4.42 | |
| Free Cash Flow Per Share | -1.79 | -0.24 | -2.25 | -2.30 | -0.86 | |
| Gross Margin | 100.00% | 100.00% | - | 100.00% | 100.00% | |
| Operating Margin | -524.69% | -10.32% | - | -2423.88% | 19.49% | |
| Profit Margin | -487.05% | 0.07% | - | -2151.73% | -3.93% | |
| Free Cash Flow Margin | -493.79% | -11.71% | - | -2420.53% | -27.38% | |
| EBITDA | -10.31 | -1.11 | -17.9 | -12.11 | 3.15 | |
| EBITDA Margin | - | -9.95% | - | - | 19.49% | |
| D&A For EBITDA | 0.06 | 0.04 | 0.03 | 0.01 | 0 | |
| EBIT | -10.37 | -1.16 | -17.93 | -12.12 | 3.15 | |
| EBIT Margin | - | -10.31% | - | - | 19.49% | |
| Effective Tax Rate | - | 7.54% | - | - | - | |
| Revenue as Reported | 1.98 | 11.2 | -2.85 | 0.5 | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.